Shaw and Partners is delighted to be involved in NexGen Energy's A$250m capital raise with the objective of raising the liquidity of the stock on the ASX.
Earlier this year we in... Read More
Shaw and Partners is pleased to be appointed as Joint Lead Manager to the proposed capital raising by Gyder Surgical Pty Limited (unlisted).
The Company is proposing to raise approximately A$5.3 million by way of an Unlisted Convertible Note issuance issued at $1.00 per note.
Funds will be used for key personnel hires for US and Australia commercial product launch, the commercial launch in US and Australia (expected H1 2023) and inventory build & working capital.
Gyder Surgical Pty Limited is an Australian medical device company focused on improving the accuracy, cost effectiveness and ease of orthopaedic surgery using patented technology.
The patented GYDER™ System is an intraoperative, surgical navigation tool to assist orthopaedic surgeons to position the prosthetic acetabular cup during hip replacement surgery (initial core use case). The GYDER™ System is a low cost, easy to use alternative to the current crop of complicated and costly navigation products.
The offer is available to Australian Sophisticated and Professional Investors only.
| {{data.Symbol}} {{data.CompanyName}} | {{data.Close}} {{data.AsAt | date :'shortTime'}} | {{data.Movement | number : 2}} {{data.MovementPercent | number: 2}}% |